全文获取类型
收费全文 | 5333篇 |
免费 | 351篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 114篇 |
妇产科学 | 171篇 |
基础医学 | 734篇 |
口腔科学 | 81篇 |
临床医学 | 415篇 |
内科学 | 1060篇 |
皮肤病学 | 255篇 |
神经病学 | 354篇 |
特种医学 | 312篇 |
外国民族医学 | 1篇 |
外科学 | 990篇 |
综合类 | 24篇 |
一般理论 | 8篇 |
预防医学 | 273篇 |
眼科学 | 136篇 |
药学 | 355篇 |
中国医学 | 4篇 |
肿瘤学 | 323篇 |
出版年
2021年 | 52篇 |
2020年 | 50篇 |
2019年 | 53篇 |
2018年 | 65篇 |
2017年 | 65篇 |
2016年 | 92篇 |
2015年 | 124篇 |
2014年 | 166篇 |
2013年 | 177篇 |
2012年 | 255篇 |
2011年 | 250篇 |
2010年 | 172篇 |
2009年 | 161篇 |
2008年 | 194篇 |
2007年 | 225篇 |
2006年 | 231篇 |
2005年 | 225篇 |
2004年 | 197篇 |
2003年 | 209篇 |
2002年 | 194篇 |
2001年 | 192篇 |
2000年 | 202篇 |
1999年 | 159篇 |
1998年 | 81篇 |
1997年 | 69篇 |
1996年 | 46篇 |
1995年 | 52篇 |
1994年 | 46篇 |
1993年 | 40篇 |
1992年 | 94篇 |
1991年 | 90篇 |
1990年 | 119篇 |
1989年 | 91篇 |
1988年 | 61篇 |
1987年 | 69篇 |
1986年 | 64篇 |
1985年 | 64篇 |
1984年 | 57篇 |
1983年 | 53篇 |
1980年 | 42篇 |
1979年 | 67篇 |
1978年 | 39篇 |
1977年 | 42篇 |
1976年 | 39篇 |
1975年 | 63篇 |
1974年 | 43篇 |
1973年 | 59篇 |
1972年 | 39篇 |
1970年 | 41篇 |
1969年 | 35篇 |
排序方式: 共有5691条查询结果,搜索用时 15 毫秒
991.
Diagnostic imaging in femur head necrosis 总被引:9,自引:0,他引:9
Diagnosis of avascular necrosis (AVN) of the hip has been improved by the technical progress of imaging modalities during the last decade. For a long period, only plain radiographs had been available. Scintigraphy and computed tomography contributed to differential diagnosis and early detection of bone necrosis. In the meantime, MR imaging has gained special value in the evaluation of AVN. It is now the method of choice for early detection as well as for assessment in later stage disorders. Using the ARCO system, all imaging modalities and their diagnostic viability are described. Findings regarding the different stages of AVN are correlated to tissue-specific changes. 相似文献
992.
Martins K Ahrenholz P Matic GB Hofmann D Tiess M Winkler RE Ramlow W 《Artificial organs》2000,24(7):526-532
Release of microparticles into the blood during extracorporeal circulation must be kept low because of possibly serious acute and chronic adverse effects. Concentration and size distribution of microparticles were measured during simulated treatments (n = 7) on original equipment for 2 standard low-density lipoprotein (LDL) elimination procedures (DALI 750, Fresenius AG, St. Wendel, Germany and Liposorber, Kaneka Corporation, Osaka, Japan) and compared to hemofiltration solutions. For both systems as well as in hemofiltration solutions, the mean particle concentrations in 500 ml portions gathered from the efferent blood line stayed below 10% of pharmacopoeia standards for infusion solutions (United States Pharmacopoeia, European Pharmacopoeia) in all measured size classes. Although particle concentrations were comparable in all systems, the mean total number of particles > or =2 microm released per session was lowest in the DALI (167,000) compared to the Liposorber (465,000) and hemofiltration solutions (2,240,000). This was mainly due to different total processed blood volumes necessary to achieve the required LDL reduction. 相似文献
993.
Matic G Hofmann D Winkler R Tiess M Michelsen A Schneidewind JM Hebestreit G Keysser M Müller W Kinze EM Ramlow W 《Artificial organs》2000,24(2):103-107
Elimination of IgG can be achieved by extracorporeal immunoadsorption (IA) based on specific binding to either staphylococcal protein A (Excorim) or sheep polyclonal antibodies directed against human IgG (Therasorb). In 602 analyzed sessions of IA, elimination of IgG was 60% through 80% depending on the treated plasma volume, with no significant difference between the mentioned systems. However, the decrease of IgM and IgA was approximately 50% in the anti-IgG compared to 20-40% in the protein A system. Plasma albumin concentration decreased by 20% in the anti-IgG system compared to 15% in the protein A system, and hemoglobin values increased by 2% in the anti-IgG system and decreased by 6% in the protein A system. In conclusion, a clinical relevance for these findings cannot be ruled out, and the individual choice might depend on the clinical situation and laboratory findings. 相似文献
994.
Hofmann M Nussbaum AK Emmerich NP Stoltze L Schild H 《Expert opinion on therapeutic targets》2001,5(3):379-393
The vertebrate immune system monitors whether an organism is invaded by pathogens. Therefore, each cell has to prove itself as healthy. This is achieved by presenting fragments of intracellular protein degradation products on the surface, i.e., each cell displays peptides on specialised proteins known as major histocompatibility complex (MHC) class I proteins. A displayed peptide has to pass certain constraints before its presentation: It has to be excised out of a protein, translocated into the endoplasmic reticulum (ER) and fit into the binding groove of a MHC molecule. In theory, alteration of the cellular protein profile by mutation or infection should force pathogen-specific T-cells to take action via recognition of foreign peptide bound to MHC class I molecules on the cell surface. Unfortunately, pathogens and tumours have evolved many ways to affect antigen presentation and to escape from immune response. Understanding the exact mechanisms of antigen presentation, i.e., protein cleavage and peptide binding by MHC molecules, would allow their manipulation by drugs and lead to the re-establishment of the correct antigen presentation pathway. This review will summarise current knowledge of the mechanisms of antigen presentation and discuss putative targets for therapeutic treatment as well as for vaccination strategies. 相似文献
995.
In 1999, the World Health Organization (WHO) Department of Vaccines and Biologicals launched the Immunisation Safety Priority Project to boost its activities in this area, with the aim of establishing a comprehensive system to ensure the safety of all immunisations given in national immunisation programmes. Countries are the primary focus of this project. The WHO has a role to play not only because of its technical and normative role but also because of its privileged relationship with country authorities and other partners, its global vision and mandate, and because it is perceived as free from conflicts of interest. There are four areas of focus in the project: quality control and assessment tools to ensure vaccine safety from clinical trials up to and including the point of use;research and development of safer and simpler delivery systems; access to safer and more efficient systems for vaccine delivery and sharps waste management; and mechanisms to respond promptly and effectively to vaccine safety concerns. The project emphasises the importance of advocating safety and developing necessary infrastructure and human resource to properly deal with immunisation related safety issues at a national level. 相似文献
996.
F J T Staal G Cario G Cazzaniga T Haferlach M Heuser W-K Hofmann K Mills M Schrappe M Stanulla L U Wingen J J M van Dongen B Schlegelberger 《Leukemia》2006,20(8):1385-1392
A plethora of studies have documented that gene expression profiling using DNA microarrays for various types of hematological malignancies provides novel information, which may have diagnostic and prognostic implications. However, to successfully use microarrays for this purpose, the quality and reproducibility of the whole procedure need to be guaranteed. Critical steps of the method are handling, processing and storage of the leukemic sample, purification of tumor cells (or lack thereof), RNA extraction methods, quality control of RNA, labeling techniques, hybridization, washing, scanning, spot filtering, normalization and initial interpretation, and finally the biostatistical analysis. These items have been extensively discussed and evaluated in different multi-center quality rounds within the three networks, that is, I-BFM-SG, the German Competence Network 'Acute and Chronic Leukemias' and the European LeukemiaNet. Based on the exchange of knowledge and experience between the three networks over the last few years, we have formulated guidelines for performing microarray experiments in leukemia. We confine ourselves to leukemias, but many of these requirements also apply to lymphomas or other clinical samples, including solid tumors. 相似文献
997.
998.
Hofmann UB Becker JC Bröcker EB 《Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete》2002,53(9):587-595
Cutaneous melanoma is an invasive and early metastazising tumor. Melanoma cells detach from the primary tumor, penetrate the basement membrane, invade lymphatics and blood vessels, and form metastases. These processes all depend on coordinated expression and/or activation of proteolytic enzymes. In addition to aspartyl- and cysteineproteinases, serine proteinases including the plasminogen activator system (uPA, uPAR, tPA, PAI-1 and PAI-2) and matrix metalloproteinases (MMPs) with their tissue inhibitors (TIMPs) play an essential role in these processes. In addition, melanoma cells require specific adhesion molecules such as integrins and CD44 for interaction with other cells and components of the extracellular matrix (ECM); these are also involved in binding activated MMPs on the cell surface. In this review we discuss these functional aspects of melanoma progression. 相似文献
999.
1000.
H. Hofmann O. Schmut 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》1977,204(4):281-285
Zusammenfassung Aus Rinderglaskörper wurde pepsin-lösliches Kollagen isoliert, das bei der Untersuchung mit der Disk-Elektrophorese eine -Komponente zeigte, die im 1-Bereich wanderte. Auffallend sind mehrere Farblinien zwischen der - und der -Komponente. Bei der Disk-Elektrophorese der Bromcyan-Peptide von pepsin-löslichem Glaskörperkollagen kann festgestellt werden, daß das Peptidmuster nicht mit dem identisch ist, das aus pepsin-löslichem Typ II Kollagen erhalten werden kann.
Comparison of the cyanogen bromide peptides of vitreous body collagen and type II collagen
Summary Pepsin-soluble collagen was isolated from bovine vitreous humor. This collagen showed only one -chain in disc electrophoresis, migrating in the 1-chain position and between the - and -components some colored bands were visible. The disc electrophoretic patterns of the cyanogen bromide peptides of pepsinsoluble vitreous body collagen and pepsin-soluble type II collagen revealed no identity.相似文献